RecruitingNCT06556888
Observatory of Immunological Thrombopenic Purpura in the Brest Region
Observatory of Immunological Thrombopenic Purpura in the Brest Region: Descriptive and Comparative Cross-sectional Study
Sponsor
University Hospital, Brest
Enrollment
500 participants
Start Date
Jun 20, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
Database of patients with ITP, diagnosed, treated and followed in the Brest University Hospital.
Eligibility
Inclusion Criteria1
- Patients with ITP agree to participate
Exclusion Criteria3
- Other thrombocythopenia other than ITP
- Patients Under guardianship
- Patients without national social security
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06556888
Related Trials
Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
NCT0710456540 locations
Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
NCT0700796224 locations
Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)
NCT072975631 location
Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)
NCT072340191 location
Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis
NCT048004581 location